Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study

<div>Survival analysis of the high ER (ER &gt; 10%, <i>H</i> group) and low ER (1% &lt; ER &lt; 10%, <i>L</i> group) group. Kaplan–Meier survival curves were plotted, and the log-rank test was performed to compare the overall survival and disease-free survival between the <i>H</i> group and the <i>L</i> group.</div>

The Breast Journal

fig2

Figure 2

Figure 2: Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study 

Figure 2 | Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study 